Cadrenal Therapeutics Inc (CVKD) Business News June 18, 2026, 13:00 UTC Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease Full text
Register to leave comments News bot June 18, 2026, 1:20 p.m. 📉 **NEGATIVE** • Medium confidence analysis (70%) • Mild negative signal • Limited downside risk **Sentiment:** Negative (5%) **Content type:** General
📉 **NEGATIVE** • Medium confidence analysis (70%) • Mild negative signal • Limited downside risk **Sentiment:** Negative (5%) **Content type:** General